About us

The INTERCEPT (INTercEption of oRal CancEr develoPmenT) COST Action addresses the challenge of unmet oral cancer prevention and bring new paradigm to disease management of oral potentially malignant disorders (OPMD). Relying on excellent translational research, patient care and education in Europe (EU) in the field of cancer medicine, INTERCEPT will develop future strategies of personalized OPMD preventive and care approaches. Pluridisciplinary expertise will involve and target a spectrum of keys actors to ensure a long-term success.

Management Committee:

Albania

Dr Stela PANTEQI

Belgium

Ms Antonella CARDONE

Belgium

Prof Senada KOLJENOVIC

Bosnia and Herzegovina

Prof Amina HUSEINBEGOVIC

Bosnia and Herzegovina

Prof Verica PAVLIĆ

Croatia

Dr Petar OZRETIĆ

Cyprus

Dr Katerina STRATI

Estonia

Prof Ülle VOOG-ORAS

France

Prof Chloe BERTOLUS

Germany

Prof Urs MÜLLER-RICHTER

Greece

Prof Efstathios EFSTATHOPOULOS

Greece

Prof Kalliopi PLATONI

Hungary

Prof Katalin NAGY

Hungary

Dr Zoltán TAKÁCSI-NAGY

Ireland

Dr Gary MORAN

Israel

Prof Moshe ELKABETS

Italy

Prof Paolo BOSSI

Italy

Dr Susanna CHIOCCA

Latvia

Prof Ingrida CEMA

Latvia

Ms Madara DZUDZILO

Luxembourg

Dr Yves GOBEL

Luxembourg

Dr Nikolai GONCHARENKO

Malta

Dr Joanna BASIC

Malta

Dr Maria Luisa GAINZA CIRAUQUI

Netherlands

Prof Valesca RETEL

North Macedonia

Dr Slavica KOSTADINOVA KUNOVSKA

North Macedonia

Prof Kristina MITIKJ

Norway

Prof Daniela Elena COSTEA

Norway

Prof Dipak SAPKOTA

Poland

Prof Wojciech GOLUSIŃSKI

Portugal

Prof Rui AMARAL MENDES

Portugal

Dr Rui VITORINO

Romania

Prof Victor Vlad COSTAN

Romania

Prof aLINA ORMENISAN

Spain

Prof Lopez-Jornet PIA

Turkey

Prof Merva SOLUK TEKKESIN

Turkey

Prof Bengü YALDIZ ÇOBANOĞLU

United Kingdom

Prof Keith HUNTER

United Kingdom

Dr Ali KHURRAM

Keep up with the latest news,
subscribe our Newsletter

linkedin

linkedin   x  

Project information

INTERCEPTOR aims to address the challenge of generating innovative and actionable pathways by engaging with the ‘critical practice’ dimensions of transformation.

A ‘critical practice’ approach explores transformation processes in practice across different dimensions which include research, policy, business, community and individual practices.

Action Contacts

Prof. Pierre Saintigny
Action Chair
+33(0)4 69 85 60 97
pierre.saintigny@lyon.unicancer.fr

Prof. Senada Koljenovic
Action Vice Chair
+31652090524
senada.koljenovic@uza.be

COST Contacts

Dr Rosella Magli
Science Officer
+3225333833
Rossella.Magli@cost.eu

Ms Carmencita Malimban
Administrative Officer
+3225333842
carmencita.malimban@cost.eu

COST    EN FUNDED

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu